Literature DB >> 10676853

Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF).

R Mössner1, S Daniel, D Albert, A Heils, O Okladnova, A Schmitt, K P Lesch.   

Abstract

The serotonin transporter (5-HTT) regulates serotonergic neurotransmission by determining the magnitude and duration of serotonergic responses. We have recently described a polymorphism in the 5-HTT gene promoter (5-HTTLPR) which influences the function of the 5-HTT and is associated with several psychiatric disorders. Immortalized B lymphocytes express the 5-HTT, and a B lymphocyte line has been shown to express the receptor for brain-derived neurotrophic factor, trkB. Since brain-derived neurotrophic factor (BDNF) is a specific growth and differentiation factor for serotonergic neurons, we assessed whether BDNF is able to modulate 5-HTT function in B lymphoblasts. Nerve growth factor (NGF), another neurotrophin which acts via the trkA receptor, was also studied. Eight immortalized B lymphoblast lines were generated and genotyped for the 5-HTTLPR. After treatment with BDNF or NGF, 5-HT uptake and proliferation of the cell lines were assessed. Two of the B cell lines showed a dose-dependent reduction of 5-HT uptake after exposure to BDNF. Both of these cell lines were homozygous for the long allele of the 5-HTTLPR. NGF did not influence 5-HT uptake or cellular proliferation in any of the cell lines. Thus, BDNF but not NGF may influence 5-HT uptake in some B lymphocytes. The fact that regulation of the 5-HTT was observed preferentially in cells of the long/long genotype indicates that presence of a short allele confers reduced regulatory capacity on the 5-HTT. In conclusion, B lymphoblasts represent a practical model for functional regulation of the 5-HTT by neurotrophins in serotonergic neurons.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10676853     DOI: 10.1016/s0197-0186(99)00122-9

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  43 in total

Review 1.  BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity.

Authors:  J J Rakofsky; K J Ressler; B W Dunlop
Journal:  Mol Psychiatry       Date:  2011-09-20       Impact factor: 15.992

Review 2.  Brain-derived neurotrophic factor and neuropsychiatric disorders.

Authors:  Anita E Autry; Lisa M Monteggia
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

Review 3.  Pharmacogenetics and psychiatry.

Authors:  Amlan Basu; Eva Tsapakis; Kathy Aitchison
Journal:  Curr Psychiatry Rep       Date:  2004-04       Impact factor: 5.285

4.  BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression.

Authors:  George S Alexopoulos; Charles E Glatt; Matthew J Hoptman; Dora Kanellopoulos; Christopher F Murphy; Robert E Kelly; Sarah S Morimoto; Kelvin O Lim; Faith M Gunning
Journal:  J Affect Disord       Date:  2010-03-25       Impact factor: 4.839

5.  Neurobiological Underpinnings of the Estrogen - Mood Relationship.

Authors:  Whitney Wharton; Carey E Gleason; Sandra R M S Olson; Cynthia M Carlsson; Sanjay Asthana
Journal:  Curr Psychiatry Rev       Date:  2012-08-01

6.  The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis.

Authors:  Yu Pei; Alicia K Smith; Yongjun Wang; Yanli Pan; Jian Yang; Qi Chen; Weigang Pan; Feng Bao; Lisha Zhao; Changle Tie; Yizheng Wang; Jian Wang; Wenfeng Zhen; Jinxia Zhou; Xin Ma
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-18       Impact factor: 3.568

7.  Pharmacogenetics of antidepressive treatment.

Authors:  Astrid Zobel; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-01-03       Impact factor: 5.270

8.  BDNF Val66Met and cognition: all, none, or some? A meta-analysis of the genetic association.

Authors:  S D Mandelman; E L Grigorenko
Journal:  Genes Brain Behav       Date:  2011-12-05       Impact factor: 3.449

Review 9.  The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy.

Authors:  M Notaras; R Hill; M van den Buuse
Journal:  Mol Psychiatry       Date:  2015-03-31       Impact factor: 15.992

Review 10.  Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.

Authors:  Andrew J Levine; Stella E Panos; Steve Horvath
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.